Sabino Hazael Avila-Rojas

Dr. Sabino Hazael Avila-Rojas


Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2020 in Free Radical Biology and Medicine
Verified
Journal Article
Closed access
OAOmar Emiliano Aparicio-Trejo
Omar Emiliano Aparicio-Trejo
SASabino Hazael Avila-Rojas
Sabino Hazael Avila-Rojas
ETEdilia Tapia
Edilia Tapia
PRPedro Rojas-Morales
Pedro Rojas-Morales
JLJuan Carlos León-Contreras
Juan Carlos León-Contreras
José Pedraza-ChaverriJosé Pedraza-Chaverri
José Pedraza-Chaverri

1 February 2017 in European Journal of Pharmacology
Verified
Journal Article
Closed access
ASAna Belen Salinas-Abarca
Ana Belen Salinas-Abarca
SASabino Hazael Avila-Rojas
Sabino Hazael Avila-Rojas
PBPaulino Barragán-Iglesias
Paulino Barragán-Iglesias
JPJorge Baruch Pineda-Farias
Jorge Baruch Pineda-Farias
VGVinicio Granados-Soto
Vinicio Granados-Soto

1 October 2015 in Brain Research
Verified
Journal Article
Closed access
SASabino Hazael Avila-Rojas
Sabino Hazael Avila-Rojas
IVIsabel Velázquez-Lagunas
Isabel Velázquez-Lagunas
ASAna Belen Salinas-Abarca
Ana Belen Salinas-Abarca
PBPaulino Barragán-Iglesias
Paulino Barragán-Iglesias
JPJorge Baruch Pineda-Farias
Jorge Baruch Pineda-Farias
VGVinicio Granados-Soto
Vinicio Granados-Soto

1 April 2020 in Food and Chemical Toxicology
Verified
Journal Article
Closed access
LRLaura María Reyes-Fermín
Laura María Reyes-Fermín
OAOmar Emiliano Aparicio-Trejo
Omar Emiliano Aparicio-Trejo
SASabino Hazael Avila-Rojas
Sabino Hazael Avila-Rojas
TGTania Gómez-Sierra
Tania Gómez-Sierra
EMElena Martínez-Klimova
Elena Martínez-Klimova
José Pedraza-ChaverriJosé Pedraza-Chaverri
José Pedraza-Chaverri

10 July 2019 in Medicina
Verified
Journal Article
Open access
PDF file
SASabino Hazael Avila-Rojas
Sabino Hazael Avila-Rojas
ALAlejandra Lira-León
Alejandra Lira-León
OAOmar Emiliano Aparicio-Trejo
Omar Emiliano Aparicio-Trejo
LRLaura María Reyes-Fermín
Laura María Reyes-Fermín
José Pedraza-ChaverriJosé Pedraza-Chaverri
José Pedraza-Chaverri
Curcumin is a hydrophobic polyphenol compound extracted from the rhizome of turmeric. The protective effect of curcumin on kidney damage in multiple experimental models has been widely described. Its protective effect is mainly associated with its antioxidant and anti-inflammatory properties, as well as with mitochondrial function maintenance. On the other hand, occupational or environmental exposure to heavy metals is a serious public health problem. For a long time, heavy metals-induced nephrotoxicity was mainly associated with reactive oxygen species overproduction and loss of endogenous antioxidant activity. However, recent studies have shown that in addition to oxidative stress, heavy metals also suppress the autophagy flux, enhancing cell damage. Thus, natural compounds with the ability to modulate and restore autophagy flux represent a promising new therapeutic strategy. Furthermore, it has been reported in other renal damage models that curcumin’s nephroprotective effects are related to its ability to regulate autophagic flow. The data indicate that curcumin modulates autophagy by classic signaling pathways (suppression of protein kinase B (Akt)/mammalian target of rapamycin (mTOR) and/or by stimulation of adenosine monophosphate-activated protein kinase (AMPK) and extracellular signal-dependent kinase (ERK) pathways). Moreover, it allows lysosomal function preservation, which is crucial for the later stage of autophagy. However, future studies of autophagy modulation by curcumin in heavy metals-induced autophagy flux impairment are still needed.

15 May 2019 in Antioxidants
Verified
Journal Article
Open access
PDF file
LRLaura María Reyes-Fermín
Laura María Reyes-Fermín
SASabino Hazael Avila-Rojas
Sabino Hazael Avila-Rojas
OAOmar Emiliano Aparicio-Trejo
Omar Emiliano Aparicio-Trejo
ETEdilia Tapia
Edilia Tapia
IRIsabel Rivero
Isabel Rivero
José Pedraza-ChaverriJosé Pedraza-Chaverri
José Pedraza-Chaverri
Cis-dichlorodiammineplatinum II (CDDP) is a chemotherapeutic agent that induces nephrotoxicity by different mechanisms, including oxidative stress, mitochondrial dysfunction, autophagy, and endoplasmic reticulum stress. This study aimed to evaluate if the protective effects of the antioxidant alpha-mangostin (αM) in CDDP-induced damage in proximal tubule Lilly laboratory culture porcine kidney (LLC-PK1) cells, are related to mitochondrial function preservation. It was found that αM co-incubation prevented CDDP-induced cell death. Furthermore, αM prevented the CDDP-induced decrease in cell respiratory states, in the maximum capacity of the electron transfer system (E) and in the respiration associated to oxidative phosphorylation (OXPHOS). CDDP also decreased the protein levels of voltage dependence anion channel (VDAC) and mitochondrial complex subunits, which together with the reduction in E, the mitofusin 2 decrease and the mitochondrial network fragmentation observed by MitoTracker Green, suggest the mitochondrial morphology alteration and the decrease in mitochondrial mass induced by CDDP. CDDP also induced the reduction in mitochondrial biogenesis observed by transcription factor A, mitochondria (TFAM) decreased protein-level and the increase in mitophagy. All these changes were prevented by αM. Taken together, our results imply that αM’s protective effects in CDDP-induced toxicity in LLC-PK1 cells are associated to mitochondrial function preservation.